Pleomorphic adenoma (PA) |
422 |
186 |
0 |
12 |
620 (52.7%) |
Warthin's tumor |
205 |
0 |
0 |
0 |
205 (17.4%) |
Base cell adenoma (BCA) |
34 |
1 |
0 |
0 |
35 (3.0%) |
Myoepithelioma |
9 |
3 |
0 |
0 |
12 (1.0%) |
Other benign tumor |
15 |
0 |
0 |
0 |
15 (1.3%) |
Mucoepidermoid carcinoma (MEC) |
55 |
6 |
2 |
8 |
71 (6.0%) |
Adenoid cystic carcinoma (AdCC) |
15 |
20 |
4 |
13 |
52 (4.4%) |
Salivary duct carcinoma (SDC) |
16 |
11 |
0 |
0 |
27 (2.3%) |
Acinic cell carcinoma (ACC) |
31 |
4 |
0 |
0 |
35 (3.0%) |
Lymphoepithelial carcinoma (LEC) |
22 |
6 |
0 |
0 |
28 (2.4%) |
Polymorphous low-grade adenocarcinoma (PLGA) |
7 |
0 |
0 |
2 |
9 (0.8%) |
Adenocarcinoma NOS (AC NOS) |
8 |
5 |
0 |
1 |
14 (1.2%) |
Carcinoma ex PA (Ca ex PA) |
8 |
2 |
0 |
0 |
10 (0.9%) |
Epithelial-myoepithelial carcinoma (EMC) |
3 |
1 |
0 |
0 |
4 (0.3%) |
Squamous cell carcinoma |
0 |
2 |
0 |
0 |
2 (0.2%) |
Other malignant tumor |
12 |
2 |
0 |
1 |
15 (1.3%) |
Metastatic carcinoma |
4 |
0 |
0 |
0 |
4 (0.3%) |
Lymphoma |
13 |
5 |
0 |
0 |
18 (1.5%) |
Total |
879 (74.7%) |
254 (21.6%) |
6 (0.5%) |
37 (3.2%) |
1176 |